Vinay Prasad, the FDA's Biologics head, was reinstated after facing pressure from right-wing activists and criticism over his handling of a gene therapy drug.
Vinay Prasad, the FDA's Biologics head, was reinstated after facing pressure from right-wing activists and criticism over his handling of a gene therapy drug.
